# Crescent Biopharma, Inc. (CBIO) — Revenue

## Annual Revenue (USD)

| Year | Revenue |
| --- | --- |
| 2025 | $11M |
| 2023 | $10,000 |
| 2022 | $75,000 |
| 2021 | $1M |
| 2020 | $10M |
| 2016 | $18,500 |
| 2015 | $20M |
| 2014 | $15M |
| 2013 | $4M |
| 2012 | $15M |

## Quarterly Revenue (USD)

| Quarter | Revenue |
| --- | --- |
| 2026-03-31 | $1M |
| 2025-03-31 | — |
| 2022-06-30 | $75,000 |
| 2021-09-30 | $86,560 |
| 2021-06-30 | $142 |
| 2021-03-31 | $1M |
| 2020-09-30 | $1M |
| 2020-03-31 | $9M |
| 2016-09-30 | $18,500 |
| 2015-06-30 | $20M |
| 2015-03-31 | — |
| 2014-06-30 | $15M |
| 2014-03-31 | — |
| 2013-09-30 | $52,571 |
| 2013-06-30 | $55,074 |
| 2013-03-31 | $4M |

Source: [MarketCapTrends](https://marketcaptrends.com/company/CBIO/revenue)